For more ways to get exposure to the AI buildout behind these kinds of healthcare projects, explore 55 AI infrastructure stocks<\/a>. <\/p>\n Oracle operates as a large US software provider that builds, runs and supports enterprise IT frameworks worldwide. This gives it an established footing in cloud databases and data infrastructure that AstraZeneca can plug into for AI-driven healthcare work. <\/p>\n 4 things going right for Oracle that this headline doesn’t cover.<\/a> <\/p>\n How does this AstraZeneca partnership fit Oracle’s AI strategy? <\/p>\n Oracle is already supplying AI ready cloud and data infrastructure to sectors that handle sensitive information. Working with AstraZeneca on real world clinical data and trial matching extends that into regulated healthcare, using the same Oracle Cloud and database strengths that underpin its broader AI workload push. <\/p>\n Does this Oracle and AstraZeneca news change the existing Narrative on ORCL? <\/p>\n The current Narrative hinges on converting a US$638b remaining performance obligation and US$75b of AI infrastructure contracts into profitable usage while managing heavy CapEx and funding needs. This healthcare deal speaks to the demand side of that thesis by adding another data intensive AI use case, but it does not reduce key risks around negative free cash flow, leverage or the timing of contract conversion. <\/p>\n See how these catalysts shape Oracle’s path to a $238 fair value<\/a>. <\/p>\n What should investors watch next to judge whether this Oracle healthcare push is working? <\/p>\n The clearest marker is whether Oracle starts disclosing concrete wins or usage metrics in healthcare, such as live deployments across multiple AstraZeneca trials or quantified AI driven patient matching volumes. Evidence that these workloads are running at scale on Oracle Cloud, and contributing to higher GPU and data platform utilization, would help show this partnership is feeding into the wider AI infrastructure story. <\/p>\n Add Oracle to your Watchlist<\/a> and get alerts as these catalysts play out. <\/p>\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. <\/p>\n Companies discussed in this article include ORCL<\/a>. <\/p>\n Have feedback on this article? Concerned about the content? Get in touch<\/a> with us directly. Alternatively, email editorial-team@simplywallst.com<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"Oracle (NYSE: ORCL) and AstraZeneca announced a partnership to advance AI-enabled healthcare solutions focused on real-world data and…\n","protected":false},"author":2,"featured_media":637006,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[2169,138,553,219,246,5932,134,527,329,37332,5933,5483,16400,7454,111,139,69,244,8499,13081,294,781,5934,5935,643,37333,7496,37334],"class_list":["post-637005","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-401k","tag-business","tag-business-news","tag-economy","tag-finance","tag-financial-information","tag-health","tag-healthcare","tag-investing","tag-investment-tools","tag-investor","tag-market-news","tag-mortgage","tag-mutual-funds","tag-new-zealand","tag-newzealand","tag-nz","tag-personal-finance","tag-quote","tag-real-estate","tag-retirement","tag-stock","tag-stock-research","tag-stock-valuation","tag-stocks","tag-suze-orman","tag-tax","tag-track-portfolio"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/637005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=637005"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/637005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/637006"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=637005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=637005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=637005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/a> NYSE:ORCL Earnings & Revenue Growth as at Oct 2026 <\/p>\n